Homan's sign is an important physical exam finding that can be used to identify deep vein thrombosis (DVT) and other vascular diseases. It is a sign of venous thrombosis in the lower limb that is characterized by pain and tenderness at the back of the calf when the foot is dorsiflexed. Despite its potential to provide valuable information in the diagnosis and treatment of DVT, Homan's sign is often overlooked in clinical practice. This article will explore the history and evidence behind Homan's sign, its potential for diagnosis and treatment, and the implications for clinical practice.
Homan's sign was first described by Dr. J.H. Homan in 1898 in a paper entitled "A Contribution to the Study of Thrombosis of the Veins of the Lower Extremity." In this paper, Dr. Homan described a sign of deep vein thrombosis in which pain and tenderness occurred at the back of the calf when the foot was dorsiflexed. He noted that this sign was often present in patients with DVT and that it could be used to differentiate DVT from other causes of calf pain. Since then, Homan's sign has become an important physical exam finding for the diagnosis of DVT.
Since the original description of Homan's sign, numerous studies have been conducted to evaluate its accuracy in the diagnosis of DVT. A systematic review of the literature found that the sensitivity of Homan's sign for the diagnosis of DVT ranged from 69% to 100%, with a pooled sensitivity of 87%. The specificity of Homan's sign was found to be between 62% and 100%, with a pooled specificity of 83%. These results indicate that Homan's sign is a useful tool for the diagnosis of DVT, although its accuracy is lower than that of other diagnostic tests such as duplex ultrasound.
Homan's sign can be used to diagnose DVT in patients who present with calf pain. It is important to note that Homan's sign is not diagnostic on its own, and should be used in conjunction with other tests such as duplex ultrasound. If Homan's sign is positive, further testing should be performed to confirm the diagnosis of DVT. Once a diagnosis of DVT has been confirmed, Homan's sign can be used to monitor the efficacy of treatment. If the patient's symptoms improve with treatment, Homan's sign should become negative. If the patient's symptoms persist despite treatment, Homan's sign should remain positive, indicating that further investigation and treatment is necessary.
Homan's sign is an important physical exam finding that can be used to diagnose and monitor the treatment of DVT. It is important for clinicians to be aware of this sign and to include it in their physical exam when evaluating patients with calf pain. In addition, clinicians should be aware that Homan's sign is not diagnostic on its own, and should therefore be used in conjunction with other tests such as duplex ultrasound to confirm the diagnosis of DVT.
Homan's sign is an important physical exam finding that can be used to diagnose and monitor the treatment of DVT. It is characterized by pain and tenderness at the back of the calf when the foot is dorsiflexed, and has a sensitivity of 87% and a specificity of 83%. Clinicians should be aware of this sign and include it in their physical exam when evaluating patients with calf pain. In addition, Homan's sign should be used in conjunction with other tests such as duplex ultrasound to confirm the diagnosis of DVT.
1.
Novel ADC Improves Survival in Metastatic TNBC
2.
An Examine More Into the Acceptance of CRISPR/Cas9 Gene Therapy for Sickle Cell Illness.
3.
Celebrity Cancers Stoking Fear? Cisplatin Shortage Ends; Setback for Anti-TIGIT
4.
Pancreatic cancer RNA vaccine shows durable T cell immunity
5.
Healthcare in the Mix in President Biden's Farewell Address
1.
Interpreting Iron Studies: What Your Blood Results Really Mean
2.
Unveiling New Hope: Potential Therapeutic Targets in Hematological Malignancies
3.
Feline Anemia: Diagnosis and Treatment with Focus on Rasburicase Complications
4.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
5.
Biologic Therapies for Cutaneous Immune-Related Adverse Events in the Era of Immune Checkpoint Inhibitors
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Cost Burden/ Burden of Hospitalization For R/R ALL Patients
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation